Mindset Pharma is a Toronto-based drug discovery business focused on creating novel and patentable psychedelic compounds for the treatment of neurological and psychiatric disorders.
Mindset has developed 4 families of novel, next-generation psychedelics with differentiated characteristics and improved safety profiles. Read More
Family 1 / MSP-1014: Psilocybin-like conjugate.
Family 2: High-potency, short-acting, psilocybin-like.
Family 3: Low-potency, long-duration for micro-dosing
Family 4: DMT/ 5-MeO-DMT-inspired compounds